Reaction Details Report a problem with these data
Target
Vasopressin V2 receptor
Ligand
BDBM466531
Substrate
n/a
Meas. Tech.
Cellular In Vitro Assay for Determining Vasopressin V2 Receptor Activity
IC50
2.80±n/a nM
Citation
 Schmeck, C; Engelen, A; Kolkhof, P; Lustig, K; Pook, E; Wasnaire, P Oxoalkyl-substituted phenyltriazole derivatives and uses thereof US Patent  US10800746 Publication Date 10/13/2020 
Target
Name:
Vasopressin V2 receptor
Synonyms:
ADHR | AVPR V2 | AVPR2 | Antidiuretic hormone receptor | DIR | DIR3 | Renal-type arginine vasopressin receptor | V2R | V2R_HUMAN | VASOPRESSIN V2 | Vasopressin V2 receptor | Vasopressin receptor
Type:
Receptor
Mol. Mass.:
40295.28
Organism:
Homo sapiens (Human)
Description:
P30518
Residue:
371
Sequence:
MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS
  
Inhibitor
Name:
BDBM466531
Synonyms:
5-(4-Chlorophenyl)-2-({1-(3-chlorophenyl)-5-[(1S,R)-1-hydroxyethyl]-1H-1,2,4-triazol-3-yl}methyl)-4-(3,3,3-trifluoro-2-oxopropyl)-2,4-dihydro-3H-1,2,4-triazol-3-one | US10800746, Example 5
Type:
Small organic molecule
Emp. Form.:
C22H17Cl2F3N6O3
Mol. Mass.:
541.31
SMILES:
CC(O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(CC(=O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1
Structure:
Search PDB for entries with ligand similarity: